Cidara Therapeutics, Mundipharma Get CHMP Approval for Rezafungin Markets – MarketWatch

Cidara Therapeutics, Mundipharma Get CHMP Approval for Rezafungin Markets – MarketWatch

 

By Chris Wack Cidara Therapeutics and Mundipharma said Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted…

  

Read More 

Markets – MarketWatch 

​